Diagnostic Test For Personalised Statin Treatment
http://www.medilexicon.com/medicalnews.php?newsid=208557
Two recent studies at Oxford have highlighted the potential healthcare and economic benefits of personalising statin treatment based on a patient's genetic risk to statin-induced myopathy. Researchers at Oxford have identified a biomarker which is highly associated with statin-induced myopathy that could form the basis of a diagnostic test for this side effect of statin use.
http://www.medilexicon.com/medicalnews.php?newsid=208557
Two recent studies at Oxford have highlighted the potential healthcare and economic benefits of personalising statin treatment based on a patient's genetic risk to statin-induced myopathy. Researchers at Oxford have identified a biomarker which is highly associated with statin-induced myopathy that could form the basis of a diagnostic test for this side effect of statin use.
